| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Innovative Medicine, R&D
1 company
Reed John C is an EVP, Innovative Medicine, R&D at JOHNSON & JOHNSON. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $7.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | JNJ Johnson & Johnson | EVP, Innovative Medicine, R&D | Sale+OE | 53,931 | $243.00 | $13,105,233.00 | -59.6% | - | - | |
| Oct 17, 2025 | JNJ Johnson & Johnson | EVP, Innovative Medicine, R&D | Sale+OE | 21,721 | $192.71 | $4,185,793.09 | -67.1% | +13.6% | - | |
| Jul 17, 2025 | JNJ Johnson & Johnson | EVP, Innovative Medicine, R&D | Sell | 19,137 | $163.55 | $3,129,829.56 | -64.2% | +17.3% | - |